MedPath

Vall d'Hebron Research Institute

Vall d'Hebron Research Institute logo
🇪🇸Spain
Ownership
Private
Established
1994-01-01
Employees
1K
Market Cap
-
Website
http://www.vhir.org

Clinical Trials

251

Active:7
Completed:125

Trial Phases

5 Phases

Phase 1:2
Phase 2:10
Phase 3:13
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (176 trials with phase data)• Click on a phase to view related trials

Not Applicable
123 (69.9%)
Phase 4
28 (15.9%)
Phase 3
13 (7.4%)
Phase 2
10 (5.7%)
Phase 1
2 (1.1%)

Integrative Diagnosis for SCD and Other RADs

Recruiting
Conditions
Sickle Cell Disease
Thalassaemia
Congenital Dyserythropoietic Anemia (CDA)
Enzyme Disorder; Anemia
Spherocytosis, Hereditary
Hemoglobin Disorder
Stomatocytosis
Anemia Due to Membrane Defect
Rare Anemia Disorders
First Posted Date
2025-10-03
Last Posted Date
2025-10-03
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
200
Registration Number
NCT07206095
Locations
🇪🇸

Hospital de la Santa Creu i Sant Pau, Barcelona, Barcelona, Spain

🇪🇸

Hospital Universitari Vall d'Hebron, Barcelona, Barcelona, Spain

🇪🇸

Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain

and more 6 locations

NOPE37: Angiogenic Factors for Managing Term Preeclampsia

Not Applicable
Not yet recruiting
Conditions
Preeclampsia
First Posted Date
2025-09-26
Last Posted Date
2025-09-26
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
750
Registration Number
NCT07193680
Locations
🇪🇸

Vall d'Hebron Hospital Campus, Barcelona, Spain

The Effect of a Probiotic Administration as an add-on Treatment in Multiple Sclerosis

Not Applicable
Recruiting
Conditions
Multiple Sclerosis
First Posted Date
2025-09-11
Last Posted Date
2025-09-23
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
80
Registration Number
NCT07168772
Locations
🇪🇸

Centre d'Esclerosi Mútiple de Catalunya (Cemcat), Barcelona, Barcelona, Spain

Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine

Recruiting
Conditions
Migraine
Episodic Migraine
Chronic Migraine, Headache
Interventions
Drug: CGRP antibody or gepant
First Posted Date
2025-09-08
Last Posted Date
2025-09-08
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
700
Registration Number
NCT07159750
Locations
🇺🇸

University of Miami, Miller School of Medicine, Miami, Florida, United States

🇦🇷

FLENI, Buenos Aires, Argentina

🇨🇱

Pontificia Universidad Católica de Chile, Santiago, Chile

and more 23 locations

A Novel Psychological Intervention for Adults With Bipolar Disorder and Attention Deficit Hyperactivity Disorder Comorbidity (VECTOR)

Not Applicable
Not yet recruiting
Conditions
ADHD
BD
First Posted Date
2025-06-26
Last Posted Date
2025-06-26
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
68
Registration Number
NCT07039903
Locations
🇪🇸

Hospital Clínic de Barcelona and Vall d'Hebron University Hospital, Barcelona, Spain

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 50
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.